LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer

Fizazi K., Tran N., Fein L. E., Matsubara N., Antolin A. R., Alekseev B. Y., ...More

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 35
  • Doi Number: 10.1200/jco.2017.35.15_suppl.lba3
  • City: Illinois
  • Country: United States Of America
  • Istanbul University Affiliated: Yes